New metabolic‐endocrine risk markers in endometrial cancer
- 1 May 1999
- journal article
- review article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 106 (5) , 402-406
- https://doi.org/10.1111/j.1471-0528.1999.tb08290.x
Abstract
No abstract availableThis publication has 72 references indexed in Scilit:
- Independent Genetic Factors Determine the Amount and Distribution of Fat in Women after the MenopauseJournal of Clinical Endocrinology & Metabolism, 1997
- Increased Circulating Levels of Insulin-Like Growth Factor-I and Decreased Circulating Levels of Insulin-Like Growth Factor Binding Protein-1 in Postmenopausal Women with Endometrial Cancer.Endocrine Journal, 1997
- Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal womenJournal of Clinical Endocrinology & Metabolism, 1996
- Case--Control Study of Endogenous Steroid Hormones and Endometrial CancerJNCI Journal of the National Cancer Institute, 1996
- Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteinsEndocrinology, 1996
- Family history and the risk of endometrial cancerInternational Journal of Cancer, 1994
- A Case-Control Study on Risk Factors for Uterine Endometrial Cancer in JapanJapanese Journal of Cancer Research, 1994
- Usual Dietary Fat Intake and Insulin Concentrations in Healthy Women TwinsDiabetes Care, 1993
- Increased steroid production by the ovarian stromal tissue of postmenopausal women with endometrial cancerJournal of Clinical Endocrinology & Metabolism, 1992
- CARBOHYDRATE METABOLISM IN PATIENTS WITH ENDOMETRIAL CARCINOMABJOG: An International Journal of Obstetrics and Gynaecology, 1974